150mg Nilocap Nilotinib Capsules

Name: 150mg Nilocap Nilotinib Capsules
Brand: Amari Trade Alliance LLP
Price: 1000 INR
Availability: InStock

Price 1000 INR/ Box

Get a Price/Quote

MOQ : 10 Boxes

150mg Nilocap Nilotinib Capsules Specification

Indication
Chronic Myeloid Leukemia (CML)

Pacakaging (Quantity Per Box)
1 Blister (4 Capsules)

Packaging Type
Blister Pack

Salt Composition
Nilotinib 150mg

Brand Name
Nilocap

Origin of Medicine
India

Dosage Form
Capsule

Life Span
24 months

Drug Type
Allopathic

Ingredients
Nilotinib

Physical Form
Capsule

Function
Anticancer

Recommended For
Blood Cancer

Dosage
150 mg

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
4 Capsules

Storage Instructions
Store below 30C

Pack Strength
150 mg/capsule

Color
Yellow cap, white body

Shelf Storage
Cool, dry place

Route of Administration
Oral

Unit Packing
Alu-Alu Strip

Prescription Required
Yes

Marketing Status
Prescription only

WHO GMP Certified
Yes

150mg Nilocap Nilotinib Capsules Trade Information

Minimum Order Quantity
10 Boxes

Supply Ability
1000 Boxes Per Month

Delivery Time
7 Days

About 150mg Nilocap Nilotinib Capsules

Introducing Nilocap Nilotinib Capsules 150mg-a sought-after solution for the distinguished management of Chronic Myeloid Leukemia (CML). Available exclusively for a limited time with competitive pricing, these peerless capsules are manufactured under WHO GMP certification in India. Each oral dose delivers 150mg of Nilotinib in a yellow-capped, white-bodied capsule, thoughtfully packaged in alu-alu blister strips. Capitalise on this exceptional anticancer therapy, suitable for adult patients, and carefully stored below 30C to maintain unmatched efficacy. Prescription required. Each box contains 4 capsules.

Comprehensive Applications and Distinct Features

Nilocap Nilotinib 150mg Capsules target blood cancer, especially Chronic Myeloid Leukemia, through effective oral administration. Highly sought-after in oncology, these capsules are reinforced by a robust WHO GMP certification. Beyond CML, they may be explored under physician supervision for related indications when clinically appropriate. Additional cellular targeting and stability, alongside precise dosing, further distinguish Nilocap from others, offering reliable choice in specialized anticancer treatments.

Packaging Excellence and Global Market Value

Nilocap arrives in an alu-alu blister strip, providing optimal outlay and freshness over a 24-month lifespan. Each box holds one blister pack of 4 capsules, ensuring ease of use. With strong market value as a peerless oncology export from India, its main export markets span Asia, Africa, and the Middle East. Prompt drop-off is prioritised to safeguard capsule quality during delivery, reflecting commitment to reliability and effectiveness.

FAQ's of 150mg Nilocap Nilotinib Capsules:

Q: How should Nilocap Nilotinib 150mg Capsules be stored for maximum effectiveness?

A: Store Nilocap Nilotinib capsules in a cool, dry place below 30C to maintain their efficacy throughout the 24-month shelf life. Always keep them in their original blister packaging until ready to use.

Q: What distinguishes Nilocap Nilotinib Capsules from similar anticancer medications?

A: Nilocap Nilotinib is manufactured under strict WHO GMP certification, ensuring distinguished quality. Its peerless formulation targets CML effectively using a precise 150mg dosage per capsule and comes securely packaged to preserve potency and stability.

Q: When should Nilocap Nilotinib 150mg Capsules be taken?

A: Nilocap should be taken exactly as directed by a physician. Follow the prescribed schedule and dosing instructions for optimal therapeutic benefit, and never self-adjust the dosage without consulting a healthcare provider.

Q: Where are Nilocap Nilotinib Capsules sourced and exported from?

A: Nilocap Nilotinib Capsules are manufactured and exported from India, with a strong track record in major markets across Asia, Africa, and the Middle East.

Q: What is the process for acquiring Nilocap Nilotinib Capsules?

A: Nilocap requires a doctor's prescription. Once prescribed, you can obtain them from authorised pharmacies or healthcare suppliers, who export and supply the capsules as per regulatory guidelines.

Q: How does Nilocap Nilotinib benefit adults with Chronic Myeloid Leukemia?

A: Nilocap Nilotinib acts as a targeted therapy against cancerous cells in CML, offering a distinguished benefit in disease control, as recognized and sought after in global oncology practice.

Tell us about your requirement